As a Barclays analyst put it, it’s been a “slow-moving car crash”. Early supply shortages pushed patients to competitors, ...

Novo Nordisk’s Wegovy faces sharp decline in growth forecasts and share value as competition intensifies and compounded drug ...

AbbVie ( ABBV) on Thursday recorded better-than-expected financials for Q2 2025 and raised its full-year earnings outlook as the company’s newer immunology drugs offset a sharp sales decline for its ...

KanawatTH Most major stock indexes across the globe ended the week lower over tariff jitters, while the focus also remained ...

Novo's shares plunged amid rising competition, missed expectations, and governance issues, exposing the risks of neglecting ...